Novartis AG (NOVN.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
As of 12:37PM CEST. Market open.
| Previous close | 92.62 |
| Open | 93.04 |
| Bid | 93.73 x 0 |
| Ask | 93.77 x 0 |
| Day's range | 93.04 - 93.85 |
| 52-week range | 79.21 - 94.52 |
| Volume | |
| Avg. volume | 3,236,359 |
| Market cap | 191.309B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 23.50 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.30 (3.56%) |
| Ex-dividend date | 07 Mar 2024 |
| 1y target est | N/A |
- Thomson Reuters StreetEvents
Q1 2024 Legend Biotech Corp Earnings Call
Q1 2024 Legend Biotech Corp Earnings Call
- The Telegraph
Questor: this medical stock is expensive – but worth paying for
It’s a stock market rule of thumb that big acquisitions tend to destroy shareholder value. Spin-offs, on the other hand, have the reassuring habit of being more likely to create it.
- Zacks
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
© 2024 Yahoo. All rights reserved.